IQVIA Form 144 filing details 56,557-share planned sale

Rhea-AI Filing Summary

IQV (issuer) — Notice of proposed sale under Form 144. A shareholder filed to sell up to 56,557 shares of common stock, with an aggregate market value of $12,460,983.24. The approximate sale date listed is 10/29/2025, and the shares are listed on the NYSE. Morgan Stanley Smith Barney LLC is named as the broker.

The securities were acquired via Stock Appreciation Rights on 10/29/2025, with 56,557 shares indicated and cash noted as the nature of payment. The filing lists 170,300,000 shares outstanding, providing context for the potential sale size.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	56557	12460983.24	170300000	10/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/29/2025	Stock Appreciation Rights	Issuer			56557	10/29/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does IQV’s Form 144 filing indicate?

It indicates a shareholder’s intent to sell up to 56,557 common shares on the NYSE.

What is the aggregate market value of the proposed IQV share sale?

The filing lists an aggregate market value of $12,460,983.24 for the 56,557 shares.

When is the approximate sale date for the IQV shares?

The approximate date of sale provided is 10/29/2025.

How were the IQV shares to be sold acquired?

They were acquired via Stock Appreciation Rights on 10/29/2025, with cash noted as the nature of payment.

How many IQV shares are outstanding per the filing?

The filing lists 170,300,000 shares outstanding.

Who is the broker named in the IQV Form 144 filing?

The broker is Morgan Stanley Smith Barney LLC (Executive Financial Services).

On which exchange are the IQV shares listed?

The filing names the NYSE as the securities exchange.